Aug 28, 2018
Neurotrope Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City September 4-6, 2018
Aug 13, 2018
Neurotrope Provides Business Update and Reports Second Quarter 2018 Financial Results
Jul 25, 2018
At AAIC 2018, Neurotrope Presents Additional Clinical Results Showing Cognitive Improvement in Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients
Jul 16, 2018
Neurotrope Announces the Initiation of Enrollment of its Confirmatory Phase 2 Trial in Alzheimer's Disease
Jul 02, 2018
Neurotrope to Present Additional Phase 2 Data at the Alzheimer's Association International Conference (AAIC) 2018 Meeting
Feb 28, 2018
Neurotrope to Present at the Cowen and Company 38th Annual Health Care Conference
Feb 07, 2018
Neurotrope to Present at BIO CEO & Investor Conference
Jan 05, 2018
Neurotrope's Bryostatin Improves Cognition in Patients with Advanced Alzheimer's Disease Based on Further Analysis of Phase 2 Clinical Trial Data
Dec 19, 2017
Neurotrope to Present Additional Findings from Bryostatin Phase 2 Trial in Advanced Alzheimer's Disease
Dec 18, 2017
Neurotrope Appoints Charles S. Ryan as Chief Executive Officer
Aug 09, 2017
Neurotrope Provides Business Update and Reports Second Quarter 2017 Financial Results
Jul 19, 2017
Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 2017
Jun 29, 2017
Neurotrope to Present Bryostatin Phase 2 Data in an Oral Presentation at AAIC 2017 Meeting